Keeping Data Continuous when Analyzing the Prognostic Impact of a Tumor Marker: An Example with Cathepsin D in Breast Cancer
- 1 November 2003
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 82 (1) , 47-59
- https://doi.org/10.1023/b:brea.0000003919.75055.e8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Predictors of distant metastasis at presentation in breast cancer: a study also evaluating associations among common biological indicatorsBreast Cancer Research and Treatment, 2001
- National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000JNCI Journal of the National Cancer Institute, 2001
- Immunohistochemical Cathepsin-D Expression in Breast Cancer: Correlation with Established Pathological Parameters and SurvivalPathology - Research and Practice, 2001
- Prognostic variables in node-negative and node-positive breast cancer - editorialBreast Cancer Research and Treatment, 1998
- Cathepsin D and breast cancerEuropean Journal Of Cancer, 1996
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994
- Prognostic value of total cathepsin D in breast tumorsBreast Cancer Research and Treatment, 1991
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990
- CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCERThe Lancet, 1989
- Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer InstitutePublished by Elsevier ,1980